中国卒中杂志 ›› 2018, Vol. 13 ›› Issue (09): 938-943.DOI: 10.3969/j.issn.1673-5765.2018.09.010

• 论著 • 上一篇    下一篇

脑梗死急性期使用丁苯酞注射液对患者脑血流灌注和认知功能的影响

邬刚, 战丽萍, 安明顺, 李妍平, 李杨, 涂坤, 王晋   

  1. 1  650051昆明医科大学附属延安医院神经内科
    2  昆明医科大学附属延安医院影像科
  • 收稿日期:2018-02-11 出版日期:2018-09-20 发布日期:2018-09-20
  • 通讯作者: 王晋 313498419@qq.com
  • 基金资助:

    云南省科技厅-昆医联合专项面上项目[2017FE468(-233),急性脑梗死伴吞咽功能障碍患者BOLD-fMRI定量与临床评估的对比研究]昆明市延安医院院内项目(yyky017-032,脑梗死急性期患者使用丁苯酞对认知功能与脑血流灌注改善的相关性)昆明市卫生和计划生育委员会医药卫生科技项目(2018-03-07-003,磁共振动脉自旋标记技术评价脑梗死急性期患者使用丁苯酞注射液对吞咽障碍的改善作用)。

Effects of Butylphthalide Injection on Cerebral Perfusion and Cognitive Function in Patients with Acute Cerebral Infarction

  • Received:2018-02-11 Online:2018-09-20 Published:2018-09-20

摘要:

目的 研究伴有认知障碍的脑梗死急性期患者使用丁苯酞注射液对脑血流灌注和蒙特利尔认知 评估量表(Montreal cognitive assessment scale,MoCA)评分的影响。 

方法 将符合入组条件的80例伴有认知障碍的脑梗死急性期患者随机分为观察组(40例)和对照 组(40例),对照组采用常规治疗,观察组在对照组治疗方法基础上联合丁苯酞注射液治疗,疗程14 d。治疗前后行磁共振动态磁敏感对比增强灌注加权成像(dynamic susceptibility contrast-enhanced perfusion weighted imaging,DSC-PWI)测量缺血区脑血流灌注参数,包括缺血区脑血流量(cerebral blood flow,CBF)比值、脑血流量(cerebral blood volume,CBV)比值、平均通过时间(mean transit time, MTT)比值和达峰时间(time to peak,TTP)比值。采用MoCA量表评估认知功能。 

结果 观察组治疗后CBF比值、CBV比值较对照组提高,MTT比值和TTP比值较对照组降低,差异均 有统计学意义。观察组治疗后MoCA各亚项评分和总评分较对照组提高,差异均有统计学意义。观察组治疗前后CBV比值、CBF比值与MoCA量表总评分呈正相关(r =0.474,P =0.013;r =0.282,P =0.027), MTT比值、TTP比值与MoCA量表总评分呈负相关(r =-0.294,P =0.021;r =-0.382,P =0.019)。 

结论 丁苯酞注射液可提高伴有认知障碍的脑梗死急性期患者缺血区脑血流灌注水平并提高 MoCA评分。

文章导读: 通过病例对照研究显示丁苯酞注射液可以改善伴有认知功能障碍的急性缺血性卒中患者的认知功能和脑血流灌注,且改善的认知功能与脑血流灌注有相关性。

关键词: 脑梗死; 认知障碍; 丁苯酞注射液; 脑血流灌注

Abstract:

Objective To investigate the effect of butylphthalide injection on cerebral blood flow perfusion and cognitive function in patients with acute cerebral infarction and cognitive impairment. Methods A total of 80 eligible patients were included in this study, all of whom were randomly divided into two groups: observation group (n =40) and control group (n =40). Conventional therapy was used in control group, while butylphthalide injection was added to conventional therapy in observation group, with a treatment course of 14 days each group. Cerebral blood flow perfusion parameters were achieved by magnetic resonance dynamic susceptibility contrast-enhanced perfusion weighted imaging (DSC-PWI), including ischemia relative cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT) and time to peak (TTP); cognitive function was assessed with Montreal cognitive assessment (MoCA) scale. The changes of cerebral perfusion and cognitive function after treatment were analyzed. Results The relative CBF and CBV had greater increase in observation group than that in control group after 14-day treatment (P <0.05), while the relative MTT and TTP had greater decrease in observation group than in control group (P <0.05). Each item score and total score of MoCA in differences (P <0.05). The CBV and CBF after treatment were positively correlated with the total score of MoCA (r =0.474, P =0.013; r =0.282, P =0.027), and the MTT and TTP were negatively correlated with the total score of MoCA (r =-0.294, P =0.021; r =-0.382, P =0.019) in observation group. Conclusion Butylphthalide injection can improve cerebral blood flow perfusion in ischemic region and MoCA scores in patients with acute cerebral infarction and cognitive impairment.

Key words: Cerebral infarction; Cognitive impairment; Butylphthalide injection; Cerebral blood flow perfusion